BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23786263)

  • 1. Reconstructed stem cell nanoghosts: a natural tumor targeting platform.
    Toledano Furman NE; Lupu-Haber Y; Bronshtein T; Kaneti L; Letko N; Weinstein E; Baruch L; Machluf M
    Nano Lett; 2013 Jul; 13(7):3248-55. PubMed ID: 23786263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreating Mesenchymal Stem Cells with Cancer Conditioned-Media or Proinflammatory Cytokines Changes the Tumor and Immune Targeting by Nanoghosts Derived from these Cells.
    Lupu-Haber Y; Bronshtein T; Shalom-Luxenburg H; D'Atri D; Oieni J; Kaneti L; Shagan A; Hamias S; Amram L; Kaneti G; Cohen Anavy N; Machluf M
    Adv Healthc Mater; 2019 May; 8(10):e1801589. PubMed ID: 30963725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoghosts as a Novel Natural Nonviral Gene Delivery Platform Safely Targeting Multiple Cancers.
    Kaneti L; Bronshtein T; Malkah Dayan N; Kovregina I; Letko Khait N; Lupu-Haber Y; Fliman M; Schoen BW; Kaneti G; Machluf M
    Nano Lett; 2016 Mar; 16(3):1574-82. PubMed ID: 26901695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer.
    Levy O; Brennen WN; Han E; Rosen DM; Musabeyezu J; Safaee H; Ranganath S; Ngai J; Heinelt M; Milton Y; Wang H; Bhagchandani SH; Joshi N; Bhowmick N; Denmeade SR; Isaacs JT; Karp JM
    Biomaterials; 2016 Jun; 91():140-150. PubMed ID: 27019026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin Loaded Poly(L-glutamic acid)-g-Methoxy Poly(ethylene glycol) Complex Nanoparticles for Potential Cancer Therapy: Preparation, In Vitro and In Vivo Evaluation.
    Yu H; Tang Z; Li M; Song W; Zhang D; Zhang Y; Yang Y; Sun H; Deng M; Chen X
    J Biomed Nanotechnol; 2016 Jan; 12(1):69-78. PubMed ID: 27301173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy.
    Kim SM; Oh JH; Park SA; Ryu CH; Lim JY; Kim DS; Chang JW; Oh W; Jeun SS
    Stem Cells; 2010 Dec; 28(12):2217-28. PubMed ID: 20945331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors.
    Jang SC; Kim OY; Yoon CM; Choi DS; Roh TY; Park J; Nilsson J; Lötvall J; Kim YK; Gho YS
    ACS Nano; 2013 Sep; 7(9):7698-710. PubMed ID: 24004438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy.
    Qi WW; Yu HY; Guo H; Lou J; Wang ZM; Liu P; Sapin-Minet A; Maincent P; Hong XC; Hu XM; Xiao YL
    Mol Pharm; 2015 Mar; 12(3):675-83. PubMed ID: 25584860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro analysis of the anti-cancer activity of mitoxantrone loaded on magnetic nanoparticles.
    Lee KJ; An JH; Chun JR; Chung KH; Park WY; Shin JS; Kim DH; Bahk YY
    J Biomed Nanotechnol; 2013 Jun; 9(6):1071-5. PubMed ID: 23858972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced antitumor efficacy by cyclic RGDyK-conjugated and paclitaxel-loaded pH-responsive polymeric micelles.
    Gao Y; Zhou Y; Zhao L; Zhang C; Li Y; Li J; Li X; Liu Y
    Acta Biomater; 2015 Sep; 23():127-135. PubMed ID: 26013038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of XIAP combined with systemic mesenchymal stem cell-mediated delivery of sTRAIL ligand inhibits metastatic growth of pancreatic carcinoma cells.
    Mohr A; Albarenque SM; Deedigan L; Yu R; Reidy M; Fulda S; Zwacka RM
    Stem Cells; 2010 Nov; 28(11):2109-20. PubMed ID: 20882532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multifunctional DNA origami as carrier of metal complexes to achieve enhanced tumoral delivery and nullified systemic toxicity.
    Huang Y; Huang W; Chan L; Zhou B; Chen T
    Biomaterials; 2016 Oct; 103():183-196. PubMed ID: 27388944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin loaded fibrinogen nanoparticles for cancer drug delivery.
    Rejinold NS; Muthunarayanan M; Chennazhi KP; Nair SV; Jayakumar R
    J Biomed Nanotechnol; 2011 Aug; 7(4):521-34. PubMed ID: 21870456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis.
    Yasukochi A; Kawakubo T; Nakamura S; Yamamoto K
    Biol Chem; 2010 Aug; 391(8):947-58. PubMed ID: 20482316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes derived from TRAIL-engineered mesenchymal stem cells with effective anti-tumor activity in a mouse melanoma model.
    Shamili FH; Bayegi HR; Salmasi Z; Sadri K; Mahmoudi M; Kalantari M; Ramezani M; Abnous K
    Int J Pharm; 2018 Oct; 549(1-2):218-229. PubMed ID: 30075248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoghosts: Harnessing Mesenchymal Stem Cell Membrane for Construction of Drug Delivery Platforms Via Optimized Biomimetics.
    Xiao Y; Xu RH; Dai Y
    Small; 2024 Jan; 20(1):e2304824. PubMed ID: 37653618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo evaluation of poly-l-asparagine nanocapsules as carriers for anti-cancer drug delivery.
    Rivera-Rodriguez GR; Lollo G; Montier T; Benoit JP; Passirani C; Alonso MJ; Torres D
    Int J Pharm; 2013 Dec; 458(1):83-9. PubMed ID: 24140546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
    Chen X; Wang X; Wang Y; Yang L; Hu J; Xiao W; Fu A; Cai L; Li X; Ye X; Liu Y; Wu W; Shao X; Mao Y; Wei Y; Chen L
    J Control Release; 2010 Jul; 145(1):17-25. PubMed ID: 20307599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxel.
    Luo LM; Huang Y; Zhao BX; Zhao X; Duan Y; Du R; Yu KF; Song P; Zhao Y; Zhang X; Zhang Q
    Biomaterials; 2013 Jan; 34(4):1102-14. PubMed ID: 23127332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.